Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocala Oncology, operating as part of Florida Cancer Specialists & Research Institute (FCS), is a premier provider of comprehensive cancer care and hematology services in North Central Florida. The center offers a full spectrum of oncology services, including medical oncology, radiation therapy, and advanced diagnostic imaging such as PET/CT scans. As a prominent clinical research site, Ocala Oncology provides patients with access to innovative Phase 1 through Phase 4 clinical trials through strategic partnerships with the Sarah Cannon Research Institute and the US Oncology Network. The practice emphasizes personalized medicine, utilizing genomic testing and targeted therapies to treat a wide variety of cancers and blood disorders. With a history spanning over 40 years in the Ocala community, the facility remains a critical hub for community-based oncology research and patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocala Oncology.